CAY10680

Tax included
A selective inhibitor of both MAO-B activity (IC50 = 34.9 nM in human) and adenosine A2A receptors (Ki = 39.5 nM in human); designed as a potential dopamine-sparing therapeutic in the treatment of Parkinson’s disease
Cayman Chemical
15618-50

Data sheet

Size
50 mg
CAS
1439488-21-7
URL - Product
http://www.caymanchem.com/pdfs/15618.pdf